Silo Pharma, Inc. (SILO) — 10-Q Filings

10-Q Filings (5)

• Silo Pharma's R&D Soars 43% Amidst Widening Losses — Nov 13, 2025 Risk: high
  Silo Pharma, Inc. (SILO) reported a net loss of $3,346,168 for the nine months ended September 30, 2025, an increase from a net loss of $2,662,260 in the same p
• Silo Pharma's R&D Spend Soars 69% Amid Widening Losses — Aug 13, 2025 Risk: high
  Silo Pharma, Inc. (SILO) reported a net loss of $2,235,730 for the six months ended June 30, 2025, a significant increase from the $1,733,446 net loss in the pr
• Silo Pharma Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Silo Pharma, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as Uppercut Brands, Inc., is inco
• Silo Pharma Files Q2 2024 10-Q Report — Aug 13, 2024 Risk: medium
  Silo Pharma, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, formerly known as Uppercut Brands, Inc., Point Capita
• Silo Pharma, Inc. Files Quarterly Report on Form 10-Q — May 13, 2024 Risk: low
  Silo Pharma, Inc. (SILO) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Silo Pharma, Inc. filed its quarterly report on Form 10-Q for the period

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX